Reliability and Validity of HHIRS General Quality of Life Questionnaire (HHIRS-GQOL)

April 27, 2022 updated by: Keramat Ullah, Helping Hand Institute of Rehabilitation Sciences

Reliability and Validity of HHIRS General Quality of Life Questionnaire in Urdu Speaking Population of Pakistan

Quality of life is conceded by copious musculoskeletal and neurogenic conditions which are evaluated by manifold questionnaires. These questionnaires are obtainable in English and many other languages but in Pakistan, these cannot be applied due to differences in languages, lifestyles, culture, and activities of daily living (ADL's). In relation to the culture of Pakistan, there are many accomplishments such as offer prayers and other domestic obligation which cannot be executed appropriately if any Musculoskeletal and neurogenic disorders are existing. All these disorders can be assessed appropriately by questionnaires previously accessible but not in a single tool.

Study Overview

Status

Completed

Conditions

Detailed Description

HHIRS developed a general quality of life questionnaire in the Urdu language for the expediency of patients. Relation of the questionnaire with upper limb has been identified but there is no clear relation with other body regions. Consequently, the purpose of this research is to evaluate the validity and reliability of the HHIRS-General-QOL Questionnaire in the Urdu Speaking Population of Pakistan.

Study Type

Observational

Enrollment (Actual)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • KPK
      • Mansehra, KPK, Pakistan, 21300
        • Helping hand Institute of Rehabilitation Sciences Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

study population targeted will be the Urdu-speaking population with any neurological or musculoskeletal pain/ disorder impacting their quality of life.

Description

Inclusion Criteria:

  • participants able to read and write Urdu
  • neurological disorders
  • musculoskeletal pain
  • systemic diseases

Exclusion Criteria:

  • communication disorder
  • cognitive disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
validity of HHIRS general quality of life questionnaire
Time Frame: 2 months
validity of questionnaire will be determined by comparing the responses of patients for HHIRS-GQOL questionnaire with GHQ-12 questionnaire
2 months
Reliability of HHIRS general quality of life questionnaire
Time Frame: 72 hours
reliability will be measured by comparing the score the score of questionnaires collected at two different occasions
72 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Helping Hand Institute of Rehabilitation Sciences

Investigators

  • Principal Investigator: keramat Ullah Keramat, HHIRS Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 20, 2021

Primary Completion (Actual)

October 20, 2021

Study Completion (Actual)

November 5, 2021

Study Registration Dates

First Submitted

April 15, 2021

First Submitted That Met QC Criteria

April 27, 2022

First Posted (Actual)

April 28, 2022

Study Record Updates

Last Update Posted (Actual)

April 28, 2022

Last Update Submitted That Met QC Criteria

April 27, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Rec.Letter/St./2021/20/03/01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Pain

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe